StockStory.org on MSN1d
ANI Pharmaceuticals (NASDAQ:ANIP): Strongest Q3 Results from the Generic Pharmaceuticals GroupEarnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look ...
Let’s dig into the relative performance of Amphastar Pharmaceuticals (NASDAQ:AMPH) and its peers as we unravel the ...
Despite increasing competition in the pharmaceutical industry, several generic drug companies are poised for growth. Though generic drugs represent more than 90% of dispensed prescriptions ...
Market OverviewThe Global Generic Drugs Market was valued at $411.99 Billion in 2022 and is projected to reach $613.34 ...
Shares in the brain drug developer rose by more than 20% Monday on news of the deal, which will forestall Teva's generic copy ...
AstraZeneca is asking a court to immediately stop generic drugmakers from their plans to make and sell generic forms of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results